Anti Obesity Medication Guideline

The prevalence of obesity and associated comorbidities is rising. This material summarized the anti-obesity medications adapted by the PES Obesity Special Interest Group from the original…

Read More

Type 2 diabetes in youth: Rationale for use of off-label antidiabetic agents

This is a perspective that very briefly summarizes the evidence at that time of publication for treatment of youth-onset type 2 diabetes, as well as some…

Read More

State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS)

Read More

The Role of Recombinant Human Insulin-Like Growth Factor-I in Treating Children with Short Stature

Read More

Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations

Read More

Position Statement on Genital Surgery in Individuals with Differences of Sex Development (DSD)/Intersex Traits

Read More

New Meds and Tech: Burosumab Twza (Crysvita – Ultragenyx Pharmaceuticals)

Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast…

Read More

New Meds and Tech: Semglee

Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc.…

Read More

New Meds and Tech: Freestyle Libre 2

Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system.…

Read More

New Meds and Tech: Riomet ER™

Riomet ER™ (metformin hydrochloride for extended-release oral suspension) was approved by the U.S. Food and Drug Administration (USFDA) on August 29, 2019 and became available in…

Read More